--%> ICGI Articles

ICGI Articles

  • Clinical utility of chromatin analysis

    Published: 20.08.2018

    For more information, please contact: Andreas Kleppe

  • Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series

    Published: 01.07.2018

    Domingo E, Camps C, Kaisaki PJ, Parsons MJ, Mouradov D, Pentony MM, Makino S, Palmieri M, Ward RL, Hawkins NJ, Gibbs P, Askautrud H, Oukrif D, Wang H, Wood J, Tomlinson E, Bark Y, Kaur K, Johnstone EC, Palles C, Church DN, Novelli M, Danielsen HE, Sherlock J, Kerr D et al.

    Lancet Gastroenterol Hepatol

    PubMed 30042065

    For more information, please contact: Hanne Askautrud

  • Association Between Proportion of Nuclei With High Chromatin Entropy and Prognosis in Gynecological Cancers

    Published: 17.04.2018

    Nielsen B, Kleppe A, Hveem TS, Pradhan M, Syvertsen RA, Nesheim JA, Kristensen GB, Trovik J, Kerr DJ, Albregtsen F, Danielsen HE

    J Natl Cancer Inst. 2018 Apr 18. doi: 10.1093/jnci/djy063

    PubMed 29684152

    For more information, please contact: Birgitte Nielsen

  • Chromatin organisation and cancer prognosis: a pan-cancer study

    Published: 31.01.2018

    Kleppe A, Albregtsen F, Vlatkovic L, Pradhan M, Nielsen B, Hveem TS, Askautrud HA, Kristensen GB, Nesbakken A, Trovik J, Wæhre H, Tomlinson I, Shepherd NA, Novelli M, Kerr DJ, Danielsen HE

    Lancet Oncol DOI: https://doi.org/10.1016/S1470-2045(17)30899-9

    PubMed 29402700

    For more information, please contact: Andreas Kleppe

  • Prognostic markers for colorectal cancer; estimating ploidy and stroma

    Published: 26.12.2017

    Danielsen HE, Hveem TS, Domingo E, Pradhan M, Kleppe A, Syvertsen RA, Kostolomov I, Nesheim JA, Askautrud HA, Nesbakken A, Lothe RA, Svindland A, Shepherd N, Novelli M, Johnstone E, Tomlinson I, Kerr R, Kerr DJ

    Ann Oncol

    PubMed 29293881

    For more information, please contact: Håvard E. Greger Danielsen

  • Role of PLZF as a tumor suppressor in prostate cancer

    Published: 07.08.2017

    Jin Y, Nenseth HZ, Saatcioglu F (2017)

    Oncotarget, 8 (41), 71317-71324

    PubMed 29050363

    For more information, please contact: Fahri Saatcioglu

  • Tumour heterogeneity poses a significant challenge to cancer biomarker research

    Published: 15.06.2017

    Cyll K, Ersvær E, Vlatkovic L, Pradhan M, Kildal W, Avranden Kjær M, Kleppe A, Hveem TS, Carlsen B, Gill S, Löffeler S, Haug ES, Wæhre H, Sooriakumaran P, Danielsen HE

    Br J Cancer

    PubMed 28618431

    For more information, please contact: Karolina Cyll

  • Computer-aided diagnostics in digital pathology

    Published: 14.06.2017

    Bengtsson E, Danielsen H, Treanor D, Gurcan MN, MacAulay C, Molnár B

    Cytometry A. 2017 Jun;91(6):551-554. doi: 10.1002/cyto.a.23151.

    Pubmed 28640523

    For more information, please contact: Håvard E. Greger Danielsen

  • BCL9L Dysfunction Impairs Caspase-2 Expression Permitting Aneuploidy Tolerance in Colorectal Cancer

    Published: 01.03.2017

    López-García C, Sansregret L, Domingo E, McGranahan N, Hobor S, Birkbak NJ, Horswell S, Grönroos E, Favero F, Rowan AJ, Matthews N, Begum S, Phillimore B, Burrell R, Oukrif D, Spencer-Dene B, Kovac M, Stamp G, Stewart A, Danielsen H, Novelli M, Tomlinson I, Swanton C

    Cancer Cell, 31 (1), 79-93

    PubMed 28073006

    For more information, please contact: Håvard E. Greger Danielsen

  • Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG

    Published: 08.12.2016

    Silva MP, Barros-Silva JD, Ersvær E, Kildal W, Hveem TS, Pradhan M, Vieira J, Teixeira MR, Danielsen HE

    Transl Oncol, 9 (6), 575-582

    PubMed 27916292

    For more information, please contact: Elin Ersvær

  • « 1 2 Previous Next » 

Chief Editor: Prof. Håvard E. Danielsen
Copyright Oslo University Hospital. Visiting address: The Norwegian Radium Hospital, Ullernchausséen 64, Oslo. Tel: 22 78 23 20